Cargando…

Insights in the Recalcitrance of Theasinensin A to Human Gut Microbial Degradation

[Image: see text] Due to low bioavailability of dietary phenolic compounds in small intestine, their metabolism by gut microbiota is gaining increasing attention. The microbial metabolism of theasinensin A (TSA), a bioactive catechin dimer found in black tea, has not been studied yet. Here, TSA was...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhibin, de Bruijn, Wouter J.C., Sanders, Mark G., Wang, Sisi, Bruins, Marieke E., Vincken, Jean-Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028050/
https://www.ncbi.nlm.nih.gov/pubmed/33619960
http://dx.doi.org/10.1021/acs.jafc.1c00727
_version_ 1783675912720482304
author Liu, Zhibin
de Bruijn, Wouter J.C.
Sanders, Mark G.
Wang, Sisi
Bruins, Marieke E.
Vincken, Jean-Paul
author_facet Liu, Zhibin
de Bruijn, Wouter J.C.
Sanders, Mark G.
Wang, Sisi
Bruins, Marieke E.
Vincken, Jean-Paul
author_sort Liu, Zhibin
collection PubMed
description [Image: see text] Due to low bioavailability of dietary phenolic compounds in small intestine, their metabolism by gut microbiota is gaining increasing attention. The microbial metabolism of theasinensin A (TSA), a bioactive catechin dimer found in black tea, has not been studied yet. Here, TSA was extracted and purified for in vitro fermentation by human fecal microbiota, and epigallocatechin gallate (EGCG) and procyanidin B2 (PCB2) were used for comparison. Despite the similarity in their flavan-3-ol skeletons, metabolic fate of TSA was distinctively different. After degalloylation, its core biphenyl-2,2′,3,3′,4,4′-hexaol structure remained intact during fermentation. Conversely, EGCG and PCB2 were promptly degraded into a series of hydroxylated phenylcarboxylic acids. Computational analyses comparing TSA and PCB2 revealed that TSA’s stronger interflavanic bond and more compact stereo-configuration might underlie its lower fermentability. These insights in the recalcitrance of theasinensins to degradation by human gut microbiota are of key importance for a comprehensive understanding of its health benefits.
format Online
Article
Text
id pubmed-8028050
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-80280502021-04-08 Insights in the Recalcitrance of Theasinensin A to Human Gut Microbial Degradation Liu, Zhibin de Bruijn, Wouter J.C. Sanders, Mark G. Wang, Sisi Bruins, Marieke E. Vincken, Jean-Paul J Agric Food Chem [Image: see text] Due to low bioavailability of dietary phenolic compounds in small intestine, their metabolism by gut microbiota is gaining increasing attention. The microbial metabolism of theasinensin A (TSA), a bioactive catechin dimer found in black tea, has not been studied yet. Here, TSA was extracted and purified for in vitro fermentation by human fecal microbiota, and epigallocatechin gallate (EGCG) and procyanidin B2 (PCB2) were used for comparison. Despite the similarity in their flavan-3-ol skeletons, metabolic fate of TSA was distinctively different. After degalloylation, its core biphenyl-2,2′,3,3′,4,4′-hexaol structure remained intact during fermentation. Conversely, EGCG and PCB2 were promptly degraded into a series of hydroxylated phenylcarboxylic acids. Computational analyses comparing TSA and PCB2 revealed that TSA’s stronger interflavanic bond and more compact stereo-configuration might underlie its lower fermentability. These insights in the recalcitrance of theasinensins to degradation by human gut microbiota are of key importance for a comprehensive understanding of its health benefits. American Chemical Society 2021-02-23 2021-03-03 /pmc/articles/PMC8028050/ /pubmed/33619960 http://dx.doi.org/10.1021/acs.jafc.1c00727 Text en © 2021 The Authors. Published by American Chemical Society Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Liu, Zhibin
de Bruijn, Wouter J.C.
Sanders, Mark G.
Wang, Sisi
Bruins, Marieke E.
Vincken, Jean-Paul
Insights in the Recalcitrance of Theasinensin A to Human Gut Microbial Degradation
title Insights in the Recalcitrance of Theasinensin A to Human Gut Microbial Degradation
title_full Insights in the Recalcitrance of Theasinensin A to Human Gut Microbial Degradation
title_fullStr Insights in the Recalcitrance of Theasinensin A to Human Gut Microbial Degradation
title_full_unstemmed Insights in the Recalcitrance of Theasinensin A to Human Gut Microbial Degradation
title_short Insights in the Recalcitrance of Theasinensin A to Human Gut Microbial Degradation
title_sort insights in the recalcitrance of theasinensin a to human gut microbial degradation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028050/
https://www.ncbi.nlm.nih.gov/pubmed/33619960
http://dx.doi.org/10.1021/acs.jafc.1c00727
work_keys_str_mv AT liuzhibin insightsintherecalcitranceoftheasinensinatohumangutmicrobialdegradation
AT debruijnwouterjc insightsintherecalcitranceoftheasinensinatohumangutmicrobialdegradation
AT sandersmarkg insightsintherecalcitranceoftheasinensinatohumangutmicrobialdegradation
AT wangsisi insightsintherecalcitranceoftheasinensinatohumangutmicrobialdegradation
AT bruinsmariekee insightsintherecalcitranceoftheasinensinatohumangutmicrobialdegradation
AT vinckenjeanpaul insightsintherecalcitranceoftheasinensinatohumangutmicrobialdegradation